A Two-Stage Adaptive Targeted Clinical Trial Design for Biomarker Performance-Based Sample Size Re-Estimation
Zhong Gao (),
Anindya Roy and
Ming Tan ()
Additional contact information
Zhong Gao: University of Maryland, Baltimore County
Anindya Roy: University of Maryland, Baltimore County
Ming Tan: Georgetown University
Statistics in Biosciences, 2016, vol. 8, issue 1, No 5, 66-76
Abstract:
Abstract Biomarker-directed targeted clinical trial is aimed at developing pharmaceutical agents for a targeted patient subpopulation sharing a specific disease etiology. Biomarker plays a key role in patient enrichment for targeted trials. Biomarker performance substantially impacts heterogeneity of a targeted study population and consequently trial efficiency, statistical power, information accumulation, and early stopping decision-making (Simon and Maitournam in Clinical Cancer Res 10:6759-6763, 2004; Maitournam and Simon in Stat Med 24:329-339, 2005; Gao et al. in Contemp Clin Trials 42:119-131, 2015). Hence, accurate assessment of biomarker performance is crucial to sample size calculation in planning of targeted trials. However, prior knowledge of biomarker performance is often limited at the planning stage due to inadequacy of biomarker validation, differences between study populations in demographic characteristics and trial settings, etc. Under this circumstance, adaptive design would be useful in updating biomarker performance and re-estimating sample sizes when a targeted trial is ongoing. In this paper, we propose a two-stage adaptive design that provides flexibility in biomarker performance-based sample size adaption for targeted trials. The design can facilitate a targeted trial to achieve planned statistical power by re-assessment of actual biomarker performance and subsequent sample size adaption while preserving desired type-1 error.
Date: 2016
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
http://link.springer.com/10.1007/s12561-015-9139-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:stabio:v:8:y:2016:i:1:d:10.1007_s12561-015-9139-3
Ordering information: This journal article can be ordered from
http://www.springer.com/journal/12561
DOI: 10.1007/s12561-015-9139-3
Access Statistics for this article
Statistics in Biosciences is currently edited by Hongyu Zhao and Xihong Lin
More articles in Statistics in Biosciences from Springer, International Chinese Statistical Association
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().